浩博,浩博医药,浩博医药官网,Ausperbio,AHB-137,杭州浩博医药有限公司,杭州浩博
Ausperbio-Test
浩博,浩博医药,浩博医药官网,Ausperbio,AHB-137,杭州浩博医药有限公司,杭州浩博
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing oligonucleotide therapeutics. Leveraging our innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, we strive to unleash the power of ASO therapeutics to treat a wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases, and to transform patient lives.